BACKGROUND The relationship between non-alcoholic fatty liver disease (NAFLD) and atrial fibrillation (AF) in type 2 diabetes is currently unknown. We examined the relationship between NAFLD and risk of incident AF in people with type 2 diabetes. METHODS AND RESULTS We prospectively followed for 10 years a random sample of 400 patients with type 2 diabetes, who were free from AF at baseline. ...

Non-alcoholic fatty liver disease (NAFLD) is one of the major global health issues, strongly correlated with insulin resistance, obesity and oxidative stress. The current study aimed to evaluate anti-NAFLD effects of three different extracts of Phyllanthus niruri (P. niruri). NAFLD was induced in male Sprague-Dawley rats using a special high-fat diet (HFD). A 50% methanolic extract (50% ME) exh...

Non-alcoholic fatty liver disease (NAFLD) is a widespread closely associated with obesity and metabolic disorders. Noninvasive instrumental markers are of great importance in the diagnosis NAFLD. The aim present investigation was to study correlation Hamaguchi score prevalence peripheral arterial atherosclerosis evaluate diagnostic value relation presence carotid lower limb stenoses. Materials ...

Abstract Background Several molecular prediction models based on the clinical parameters had been constructed to predict and diagnosis risk of NAFLD, but accuracy these remains need be verified most accurate NAFLD diagnostic method. The aim this study was verify three Fatty liver index (FLI), fat score system (NAFLD LFS), Liver (%) in MRI-PDFF diagnosed Chinese Han population. Patients methods ...

Evidence suggests that nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are associated with an increased risk of chronic kidney disease (CKD). In this study we aimed to evaluate whether the severity of liver fibrosis estimated by NAFLD fibrosis score is associated with higher prevalence of CKD in individuals with NAFLD. To this end NAFLD fibrosis score and estim...

In patients with nonalcoholic fatty liver disease (NAFLD), prognosis and outcome, especially non-liver-related mortality, remain incompletely elucidated. We clarified the mortality from all causes in patients with NAFLD. A total of 4,073 patients with NAFLD diagnosed by ultrasonography were enrolled. We investigated the causes of death and analyzed the mortality from non-liver-related diseases ...

BACKGROUND AIMS Liver inflammation is a risk factor for the progression of nonalcoholic fatty liver disease (NAFLD). However, the diagnosis of liver inflammation is very difficult and invasive liver biopsy is still the only method to reliably detect liver inflammation. We previously reported that overexpression of CD14 in Kupffer cells may trigger the progression to nonalcoholic steatohepatitis...

conclusions our comprehensive literature review showed that our study was the first investigation in iran and the region, which determined the prevalence of nafld based on tissue diagnosis. we believe that the prevalence of nafld/nash in our donors can represent the overall prevalence in this age group in iran. results among 116 cases, two were diagnosed as probable nash. there was a significan...

BACKGROUND There are no licensed treatments for non alcoholic fatty liver disease (NAFLD) in adults or children. In NAFLD, several studies have shown a benefit of omega-3 fatty acid treatment on lipid profile, insulin-sensitivity and hepatic steatosis and it has also been suggested that Vitamin D treatment has potential antifibrotic properties in liver disease. TRIAL DESIGN To date, however, ...

BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the community. However, NAFLD remains undiagnosed in most people with limited access to imaging facilities in most developing countries. OBJECTIVE To examine the prevalence of NAFLD and to develop the risk scoring model for predicting the presence of NAFLD among adult medical check-up patients. METHOD A...